• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性盲法评估一种新型感测方法,旨在减少皮下植入式心律转复除颤器的不适当电击。

Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.

机构信息

Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.

Department of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Heart Rhythm. 2018 Oct;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011. Epub 2018 Jun 8.

DOI:10.1016/j.hrthm.2018.05.011
PMID:29758404
Abstract

BACKGROUND

Most inappropriate shocks from the subcutaneous implantable cardioverter-defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology, SMART Pass (SP; Boston Scientific Corporation, Natick, MA), aims to reduce cardiac oversensing.

OBJECTIVE

The purpose of this study was to evaluate the effect of SP on shocks in ambulatory patients with S-ICD.

METHODS

Patients implanted in 2015-2016 and enrolled in a remote patient monitoring system were included and followed for 1 year. Shocks were adjudicated by 3 independent blinded reviewers as appropriate or inappropriate. Shock incidence was calculated for patients with SP programmed enabled or disabled at implantation, censoring patients when SP programming changed or at the last transmission. The SP setting (enabled vs disabled) was modeled as a time-dependent Cox regression variable.

RESULTS

The cohort consisted of 1984 patients, and a total of 880 shocks were adjudicated. At implantation, SP was enabled in 655 patients (33%) and disabled in 1329 patients (67%). SP reduced the risk for the first inappropriate shock by 50% (P < .001) and the risk for all inappropriate shocks by 68% (P < .001) in multivariate analysis adjusted for age and device programming. The incidence of inappropriate shocks was 4.3% in the SP enabled arm vs 9.7% in the SP disabled arm. The incidence of appropriate shocks was similar (5.2% vs 6.6%; P = .18) along with the time to treat the first appropriate shock (17.4 seconds vs 16.7 seconds; P = .92) for SP enabled vs disabled, respectively.

CONCLUSION

This prospective blinded evaluation of the SP filter demonstrates that enabling the SP filter results in a significant reduction of inappropriate shocks by the S-ICD without a negative effect on appropriate shocks.

摘要

背景

皮下植入式心律转复除颤器(S-ICD)最不合适的电击是由心脏过度感知引起的。一种新的感知方法,即 SMART Pass(SP;波士顿科学公司,马萨诸塞州纳提克),旨在减少心脏过度感知。

目的

本研究旨在评估 SP 对 S-ICD 门诊患者电击的影响。

方法

纳入 2015-2016 年植入并纳入远程患者监测系统的患者,并随访 1 年。电击由 3 位独立的盲法审查者进行判断,分为适当或不适当。在植入时启用或禁用 SP 编程的患者中计算电击发生率,当 SP 编程改变或最后一次传输时,对患者进行删失。SP 设置(启用与禁用)被建模为一个时间依赖性 Cox 回归变量。

结果

该队列包括 1984 例患者,共判定 880 次电击。在植入时,655 例患者(33%)启用 SP,1329 例患者(67%)禁用 SP。多变量分析调整年龄和设备编程后,SP 可将首次不适当电击的风险降低 50%(P <.001),所有不适当电击的风险降低 68%(P <.001)。启用 SP 组的不适当电击发生率为 4.3%,禁用 SP 组为 9.7%。适当电击的发生率相似(5.2%对 6.6%;P =.18),启用 SP 组与禁用 SP 组首次适当电击的治疗时间也相似(17.4 秒对 16.7 秒;P =.92)。

结论

本前瞻性、盲法评估 SP 滤波器的研究表明,启用 SP 滤波器可显著减少 S-ICD 的不适当电击,而对适当电击无负面影响。

相似文献

1
Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.前瞻性盲法评估一种新型感测方法,旨在减少皮下植入式心律转复除颤器的不适当电击。
Heart Rhythm. 2018 Oct;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011. Epub 2018 Jun 8.
2
Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.家庭监测在减少植入式心脏复律除颤器患者因导线故障导致的不适当电击方面的潜在作用。
Europace. 2009 Apr;11(4):483-8. doi: 10.1093/europace/eun350. Epub 2008 Dec 22.
3
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.使用一种鉴别算法来减少皮下植入式心脏复律除颤器的不适当电击。
Heart Rhythm. 2014 Aug;11(8):1352-8. doi: 10.1016/j.hrthm.2014.04.012. Epub 2014 Apr 13.
4
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.皮下植入式心律转复除颤器(ICD)的不适当电击:发生率、预测因素及处理
Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.
5
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.多中心自动除颤器植入试验II中不适当的植入式心律转复除颤器电击:发生率、机制、预测因素及对生存的影响
J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.
6
Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.皮下植入式心脏复律除颤器导线重新定位以预防暴发性心肌炎患者因肌电位过度感知导致的不适当电击
Int Heart J. 2019 Mar 20;60(2):466-469. doi: 10.1536/ihj.18-324. Epub 2019 Feb 8.
7
Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.皮下植入式心律转复除颤器的有效性及不适当电击发放的决定因素。
Int J Cardiol. 2017 Apr 1;232:176-180. doi: 10.1016/j.ijcard.2017.01.034. Epub 2017 Jan 5.
8
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防:对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
9
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.根据电击节律对植入式心脏复律除颤器和心脏再同步治疗除颤器受者电击治疗后的生存情况。节律研究中的 ALTITUDE 生存情况。
J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.
10
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.

引用本文的文献

1
Inappropriate shock from P-wave oversensing and QRS diminution in a subcutaneous implantable cardioverter defibrillator.皮下植入式心律转复除颤器因P波感知过度和QRS波振幅降低导致不适当电击。
HeartRhythm Case Rep. 2024 Oct 5;11(1):34-37. doi: 10.1016/j.hrcr.2024.09.023. eCollection 2025 Jan.
2
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.长期随访期间经静脉与皮下植入式心律转复除颤器治疗的器械相关并发症:PRAETORIAN-XL试验
Circulation. 2025 Jul 22;152(3):172-182. doi: 10.1161/CIRCULATIONAHA.125.074576. Epub 2025 Apr 25.
3
Long-term safety and efficacy of subcutaneous implantable cardioverter-defibrillator compared with transvenous implantable cardioverter-defibrillator in propensity score-matched patients from Japan.
在倾向评分匹配的日本患者中,皮下植入式心律转复除颤器与经静脉植入式心律转复除颤器的长期安全性和有效性比较
J Arrhythm. 2025 Apr 11;41(2):e70063. doi: 10.1002/joa3.70063. eCollection 2025 Apr.
4
Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy.室性心律失常以及抗心动过速起搏在电心脏疾病和肥厚型心肌病患者中的作用。
Int J Cardiol Congenit Heart Dis. 2024 Dec 28;19:100562. doi: 10.1016/j.ijcchd.2024.100562. eCollection 2025 Mar.
5
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: .皮下植入式除颤器与经静脉植入式除颤器在缺血性心肌病患者中的临床性能:.
Front Cardiovasc Med. 2025 Feb 19;12:1539125. doi: 10.3389/fcvm.2025.1539125. eCollection 2025.
6
The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death.皮下植入式心律转复除颤器在预防心源性猝死中的作用。
US Cardiol. 2021 Oct 21;15:e19. doi: 10.15420/usc.2021.01. eCollection 2021.
7
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.皮下或经静脉植入式心律转复除颤器患者的生活质量:PRAETORIAN 试验的二次分析。
Circ Cardiovasc Qual Outcomes. 2024 Nov;17(11):e010822. doi: 10.1161/CIRCOUTCOMES.124.010822. Epub 2024 Nov 19.
8
S-ICD Implantation "Tips and Tricks".皮下植入式心律转复除颤器(S-ICD)植入术“技巧与窍门”
Rev Cardiovasc Med. 2023 Jul 10;24(7):195. doi: 10.31083/j.rcm2407195. eCollection 2023 Jul.
9
Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature.缓慢性和快速性心律失常患者的植入式心脏装置:文献综述
Rev Cardiovasc Med. 2024 May 11;25(5):162. doi: 10.31083/j.rcm2505162. eCollection 2024 May.
10
Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry.皮下植入式心律转复除颤器患者感知噪声失败的发生率、影响及处理:来自大型多中心注册研究的启示。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae161.